Pharmacophore Model Refinement
Pharmacophore Model Refinement is a computational or methodological process that iteratively optimizes the structural and physicochemical features of a pharmacophore model to enhance its predictive accuracy and biological relevance in drug discovery.
279
Publications
10.4K
Citations
1.7K
Authors
441
Institutions
Publications per year
2017–2026
77
Parents
279
Methyllycaconitine: a selective probe for neuronal α‐bungarotoxin binding sites
Joanna M. Ward, Victor B. Cockcroft, G.G. Lunt et al. · FEBS Letters · 1990 · 223 citations · Full text
Medicine, Neuroscience, Pharmacology +15
Shin-Hua Lu, Josephine W. Wu, Hsuan‐Liang Liu et al. · Journal of Biomedical Science · 2011 · 196 citations · Full text
1–5 of 279
1.7K
6
h-index
5
h-index
5
h-index
5
h-index
4
h-index
1–5 of 1.7K
441

China Pharmaceutical University
Nanjing, China
7 h-index
43 publications
957 citations

Gyeongsang National University
Jinju-si, South Korea
6 h-index
39 publications
1.5K citations

University of Karachi
Karachi, Pakistan
6 h-index
19 publications
603 citations
Shanghai Institute of Materia Medica
Pudong, China
6 h-index
27 publications
1.5K citations
International Center for Chemical and Biological Sciences
Karachi, Pakistan
5 h-index
17 publications
551 citations
University of Perugia
Perugia, Italy
5 h-index
10 publications
363 citations

Chinese Academy of Sciences
Beijing, China
5 h-index
18 publications
890 citations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
5 h-index
53 publications
2.2K citations
1–8 of 441
54 publications · 3.4K citations
36
h-index
JCIM · 15 publications · 563 citations
14
h-index
11 publications · 284 citations
11
h-index
10 publications · 211 citations
10
h-index
10 publications · 208 citations
10
h-index
1–5